{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:38:27Z","timestamp":1764603507921,"version":"3.37.3"},"reference-count":71,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["PD\/BD\/113659\/2015"],"award-info":[{"award-number":["PD\/BD\/113659\/2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Allergy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13601-018-0201-3","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T15:24:39Z","timestamp":1524151479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007\u20132012"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0233-830X","authenticated-orcid":false,"given":"Rita","family":"Amaral","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o A.","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Tiago","family":"Jacinto","sequence":"additional","affiliation":[]},{"given":"Ana M.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Andrei","family":"Malinovschi","sequence":"additional","affiliation":[]},{"given":"Christer","family":"Janson","sequence":"additional","affiliation":[]},{"given":"Kjell","family":"Alving","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1183\/13993003.01824-2014","volume":"47","author":"A Froidure","year":"2016","unstructured":"Froidure A, Mouthuy J, Durham SR, Chanez P, Sibille Y, Pilette C. Asthma phenotypes and IgE responses. Eur Respir J. 2016;47:304\u201319.","journal-title":"Eur Respir J"},{"issue":"83","key":"201_CR2","first-page":"243","volume":"15","author":"J Corren","year":"2013","unstructured":"Corren J. Asthma phenotypes and endotypes: an evolving paradigm for classification. Discov Med. 2013;15(83):243\u20139.","journal-title":"Discov Med"},{"issue":"5","key":"201_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","volume":"180","author":"PG Woodruff","year":"2009","unstructured":"Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"201_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cea.12880","volume":"47","author":"D Robinson","year":"2017","unstructured":"Robinson D, Humbert M, Buhl R, Cruz AC, Inoue H, Korom S, Hanania NA, Nair P. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161\u201375.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"201_CR5","doi-asserted-by":"publisher","first-page":"72.e12","DOI":"10.1016\/j.jaci.2013.03.044","volume":"132","author":"AT Hastie","year":"2013","unstructured":"Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, Peters SP, Meyers DA, Bleecker ER, National Heart, Lung, and Blood Institute\u2019s Severe Asthma Research Program. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol. 2013;132(1):72.e12\u201380.e12.","journal-title":"J Allergy Clin Immunol."},{"issue":"10","key":"201_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/thorax.57.10.875","volume":"57","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57(10):875\u20139.","journal-title":"Thorax"},{"issue":"4","key":"201_CR7","doi-asserted-by":"publisher","first-page":"821.e5","DOI":"10.1016\/j.jaci.2013.06.007","volume":"132","author":"A Malinovschi","year":"2013","unstructured":"Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132(4):821.e5\u201327.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"201_CR8","doi-asserted-by":"publisher","first-page":"647.e10","DOI":"10.1016\/j.jaci.2012.06.025","volume":"130","author":"G Jia","year":"2012","unstructured":"Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012;130(3):647.e10\u201354.e10.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"201_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"201_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jaci.2016.11.038","volume":"140","author":"G Jia","year":"2017","unstructured":"Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, et al. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients. J Allergy Clin Immunol. 2017;140(3):710\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"201_CR11","doi-asserted-by":"publisher","first-page":"1301.e2","DOI":"10.1016\/j.jaci.2016.01.044","volume":"138","author":"A Malinovschi","year":"2016","unstructured":"Malinovschi A, Janson C, Borres M, Alving K. Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity. J Allergy Clin Immunol. 2016;138(5):1301.e2\u2013308.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"201_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaip.2016.11.029","volume":"5","author":"RK Katial","year":"2017","unstructured":"Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, Jacobs JS, Kraft M, Martin RJ, Nair P, et al. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract. 2017;5(2):S1\u201314.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl","key":"201_CR13","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1513\/AnnalsATS.201304-087AW","volume":"10","author":"KF Chung","year":"2013","unstructured":"Chung KF, Adcock IM. How variability in clinical phenotypes should guide research into disease mechanisms in asthma. Ann Am Thorac Soc. 2013;10(Suppl):S109\u201317.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"201_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.anai.2015.12.004","volume":"116","author":"F Merritt","year":"2016","unstructured":"Merritt F. Blood eosinophils: the Holy Grail for asthma phenotyping? Ann Allergy Asthma Immunol. 2016;116(2):90\u20131.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"201_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.anai.2015.10.027","volume":"116","author":"TN Tran","year":"2016","unstructured":"Tran TN, Zeiger RS, Peters SP, Colice G, Newbold P, Goldman M, Chipps BE. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. Ann Allergy Asthma Immunol. 2016;116(1):37\u201342.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"201_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.anai.2016.04.022","volume":"117","author":"L Borish","year":"2016","unstructured":"Borish L. The immunology of asthma: asthma phenotypes and their implications for personalized treatment. Ann Allergy Asthma Immunol. 2016;117(2):108\u201314.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"201_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaip.2014.09.007","volume":"2","author":"PPW Hekking","year":"2014","unstructured":"Hekking PPW, Bel EH. Developing and emerging clinical asthma phenotypes. J Allergy Clin Immunol Pract. 2014;2(6):671\u201380.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"201_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716\u201325.","journal-title":"Nat Med"},{"issue":"2","key":"201_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1378\/chest.12-0872","volume":"143","author":"D Gibeon","year":"2013","unstructured":"Gibeon D, Batuwita K, Osmond M, Heaney LG, Brightling CE, Niven R, et al. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. Chest. 2013;143(2):406\u201314.","journal-title":"Chest"},{"key":"201_CR20","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2147\/COPD.S113647","volume":"11","author":"S Kobayashi","year":"2016","unstructured":"Kobayashi S, Hanagama M, Yamanda S, Ishida M, Yanai M. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chronic Obstr Pulm Dis. 2016;11:2117\u201323.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"1","key":"201_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","volume":"197","author":"TF Carr","year":"2018","unstructured":"Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22\u201337.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"201_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","volume":"191","author":"SA Christenson","year":"2015","unstructured":"Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758\u201366.","journal-title":"Am J Respir Crit Care Med"},{"key":"201_CR23","unstructured":"Complete Blood Count. http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/cbc_g_met_he.pdf . Accessed 17 June 2017."},{"key":"201_CR24","unstructured":"Respiratory Health ENO Procedures Manual. www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/Respiratory_Health_ENO_Procedures_Manual.pdf . Accessed 26 May 2017."},{"key":"201_CR25","unstructured":"Respiratory Health Spirometry Procedures Manual. https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/spirometry_procedures_manual.pdf . Accessed 6 June 2017."},{"issue":"8","key":"201_CR26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"ATS\/ERS","year":"2005","unstructured":"ATS\/ERS. ATS\/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"201_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"1","key":"201_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"201_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1378\/chest.09-0919","volume":"137","author":"JL Hankinson","year":"2010","unstructured":"Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults. Chest. 2010;137(1):138\u201345.","journal-title":"Chest"},{"issue":"5","key":"201_CR30","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948\u201368.","journal-title":"Eur Respir J"},{"key":"201_CR31","unstructured":"Prescription Medications - Drug Information. http:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/1999-2000\/RXQ_DRUG.htm . Accessed 6 June 2017."},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","volume":"3","author":"M Castro","year":"2015","unstructured":"Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O\u2019Brien C, Korn S. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015;3:355\u201366.","journal-title":"Lancet Respir Med"},{"issue":"26","key":"201_CR33","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455\u201366.","journal-title":"N Engl J Med"},{"issue":"10","key":"201_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","volume":"181","author":"RA Dweik","year":"2010","unstructured":"Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010;181(10):1033\u201341.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"201_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","volume":"185","author":"KW McGrath","year":"2012","unstructured":"McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV, Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med. 2012;185(6):612\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"201_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"KM Flegal","year":"1998","unstructured":"Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960\u20131994. Int J Obes Relat Metab Disord. 1998;22(1):39\u201347.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"9589","key":"201_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"AS Buist","year":"2007","unstructured":"Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741\u201350.","journal-title":"Lancet"},{"key":"201_CR38","doi-asserted-by":"crossref","unstructured":"Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). http:\/\/goldcopd.org\/asthma-copd-asthma-copd-overlap-syndrome\/ . Accessed 3 Jan 2017.","DOI":"10.5472\/MMJsi.2902.02"},{"issue":"1","key":"201_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1536867X0600600106","volume":"6","author":"KJ Archer","year":"2006","unstructured":"Archer KJ, Lemeshow S. Goodness-of-fit test for a logistic regression model fitted using survey sample data. Stata J. 2006;6(1):97\u2013105.","journal-title":"Stata J"},{"key":"201_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/JAA.S125948","volume":"11","author":"T Hirano","year":"2018","unstructured":"Hirano T, Matsunaga K. Late-onset asthma: current perspectives. J Asthma and Allergy. 2018;11:19\u201327.","journal-title":"J Asthma and Allergy"},{"key":"201_CR41","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","volume":"368","author":"SE Wenzel","year":"2006","unstructured":"Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368:804\u201313.","journal-title":"Lancet"},{"issue":"4","key":"201_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/thorax.58.4.322","volume":"58","author":"JM Vonk","year":"2003","unstructured":"Vonk JM, Jongepier H, Panhuysen CIM, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26\u00a0years of follow up. Thorax. 2003;58(4):322\u20137.","journal-title":"Thorax"},{"key":"201_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/gm259","volume":"3","author":"J Bousquet","year":"2011","unstructured":"Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med. 2011;3:43.","journal-title":"Genome Med"},{"issue":"2","key":"201_CR44","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1183\/13993003.01359-2015","volume":"47","author":"A Agusti","year":"2016","unstructured":"Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410\u20139.","journal-title":"Eur Respir J"},{"issue":"2","key":"201_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5409\/wjcp.v4.i2.13","volume":"4","author":"MM Zedan","year":"2015","unstructured":"Zedan MM, Laimon WN, Osman AM, Zedan MM. Clinical asthma phenotyping: a trial for bridging gaps in asthma management. World J Clin Pediatr. 2015;4(2):13\u20138.","journal-title":"World J Clin Pediatr"},{"issue":"5","key":"201_CR46","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jaci.2013.11.042","volume":"133","author":"W Wu","year":"2014","unstructured":"Wu W, Bleecker E, Moore W, Busse WW, Castro M, Chung KF, Calhoun WJ, Erzurum S, Gaston B, Israel E, et al. Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol. 2014;133(5):1280\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"201_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","volume":"181","author":"WC Moore","year":"2010","unstructured":"Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D\u2019Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315\u201323.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"201_CR48","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1183\/09031936.00120810","volume":"38","author":"V Siroux","year":"2011","unstructured":"Siroux V, Basaga\u00f1a X, Boudier A, Pin I, Garcia-Aymerich J, Vesin A, Slama R, Jarvis D, Anto JM, Kauffmann F, Sunyer J. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J. 2011;38(2):310\u20137.","journal-title":"Eur Respir J"},{"key":"201_CR49","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jaci.2016.08.048","volume":"139","author":"D Lefaudeux","year":"2017","unstructured":"Lefaudeux D, de Meulder B, Loza MJ, Peffer N, Rowe A, Baribaud F, Bansal AT, Lutter R, Sousa AR, Corfield J, et al. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol. 2017;139:1797\u2013807.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"201_CR50","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1513\/AnnalsATS.201508-519MG","volume":"13","author":"MJ Loza","year":"2016","unstructured":"Loza MJ, Adcock I, Auffray C, Chung KF, Djukanovic R, Sterk PJ, Susulic VS, Barnathan ES, Baribaud F, Silkoff PE, et al. Longitudinally stable, clinically defined clusters of patients with asthma independently identified in the ADEPT and U-BIOPRED asthma studies. Ann Am Thorac Soc. 2016;13(Suppl 1):S102\u20133.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"201_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12931-016-0482-9","volume":"17","author":"MJ Loza","year":"2016","unstructured":"Loza MJ, Djukanovic R, Chung KF, Horowitz D, Ma K, Branigan P, Barnathan ES, Susulic VS, Silkoff PE, Sterk PJ, et al. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. Respir Res. 2016;17(1):165.","journal-title":"Respir Res"},{"issue":"2","key":"201_CR52","doi-asserted-by":"publisher","first-page":"274.e8","DOI":"10.1016\/j.jaci.2015.03.029","volume":"136","author":"GL Clemmer","year":"2015","unstructured":"Clemmer GL, Wu AC, Rosner B, McGeachie MJ, Litonjua AA, Tantisira KG, Weiss ST. Measuring the corticosteroid responsiveness endophenotype in asthmatic patients. J Allergy Clin Immunol. 2015;136(2):274.e8\u201381.e8.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"201_CR53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaci.2016.11.003","volume":"139","author":"D Belgrave","year":"2016","unstructured":"Belgrave D, Henderson J, Simpson A, Buchan I, Bishop C, Custovic A. Disaggregating asthma: big investigation vs. big data. J Allergy Clin Immunol. 2016;139(2):400\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"201_CR54","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/all.12880","volume":"71","author":"J Bousquet","year":"2016","unstructured":"Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, Postma DS, Valenta R, Wickman M, Cambon-Thomsen A, et al. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story. Allergy. 2016;71(11):1513\u201325.","journal-title":"Allergy"},{"issue":"2","key":"201_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.metabol.2014.10.002","volume":"64","author":"LOS Leiria","year":"2015","unstructured":"Leiria LOS, Martins MA, Saad MJA. Obesity and asthma: beyond TH2 inflammation. Metabolism. 2015;64(2):172\u201381.","journal-title":"Metabolism"},{"issue":"Supplement 5","key":"201_CR56","doi-asserted-by":"publisher","first-page":"S395","DOI":"10.1513\/AnnalsATS.201702-122AW","volume":"14","author":"JHT Bates","year":"2017","unstructured":"Bates JHT, Poynter ME, Frodella CM, Peters U, Dixon AE, Suratt BT. Pathophysiology to phenotype in the asthma of obesity. Ann Am Thorac Soc. 2017;14(Supplement 5):S395\u20138.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"201_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.aller.2012.05.011","volume":"41","author":"FJ Gonzalez-Barcala","year":"2013","unstructured":"Gonzalez-Barcala FJ, Pertega S, Perez-Castro T, Sampedro M, Sanchez-Lastres J, San-Jose-Gonzalez MA, Bamonde L, Garnelo L, Vald\u00e9s-Cuadrado L, Moure JD, et al. Obesity and asthma: an association modified by age. Allergol Immunopathol (Madr). 2013;41(3):176\u201380.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"5","key":"201_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/all.12136","volume":"68","author":"M Amelink","year":"2013","unstructured":"Amelink M, De Nijs SB, De Groot JC, Van Tilburg PMB, Van Spiegel PI, Krouwels FH, et al. Three phenotypes of adult-onset asthma. Allergy. 2013;68(5):674\u201380.","journal-title":"Allergy"},{"issue":"1","key":"201_CR59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/ACI.0b013e32835c16b6","volume":"13","author":"DK Ledford","year":"2013","unstructured":"Ledford DK, Lockey RF. Asthma and comorbidities. Curr Opin Allergy Clin Immunol. 2013;13(1):78\u201386.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"201_CR60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1939-4551-7-8","volume":"7","author":"A Yanez","year":"2014","unstructured":"Yanez A, Cho S-H, Soriano JB, Rosenwasser LJ, Rodrigo GJ, Rabe KF, Peters S, Niimi A, Ledford DK, Katial R, et al. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J. 2014;7(1):8.","journal-title":"World Allergy Organ J"},{"issue":"6","key":"201_CR61","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1164\/rccm.200710-1511PP","volume":"177","author":"RL Miller","year":"2008","unstructured":"Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med. 2008;177(6):567\u201373.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"201_CR62","doi-asserted-by":"publisher","first-page":"36005","DOI":"10.1088\/1752-7155\/9\/3\/036005","volume":"9","author":"T Jacinto","year":"2015","unstructured":"Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res. 2015;9(3):36005.","journal-title":"J Breath Res"},{"issue":"3","key":"201_CR63","doi-asserted-by":"publisher","first-page":"036006","DOI":"10.1088\/1752-7163\/aa746b","volume":"11","author":"T Jacinto","year":"2017","unstructured":"Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Differential effect of cigarette smoke exposure on exhaled nitric oxide and blood eosinophils in healthy and asthmatic individuals. J Breath Res. 2017;11(3):036006.","journal-title":"J Breath Res"},{"issue":"1","key":"201_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1479972314562409","volume":"12","author":"CN Halldin","year":"2015","unstructured":"Halldin CN, Doney BC, Hnizdo E. Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chron Respir Dis. 2015;12(1):47\u201360.","journal-title":"Chron Respir Dis"},{"key":"201_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2045-7022-4-24","volume":"4","author":"A S\u00e1-Sousa","year":"2014","unstructured":"S\u00e1-Sousa A, Jacinto T, Azevedo LF, Morais-Almeida M, Robalo-Cordeiro C, Bugalho-Almeida A, Bousquet J, Fonseca JA. Operational definitions of asthma in recent epidemiological studies are inconsistent. Clin Transl Allergy. 2014;4:24.","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"201_CR66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1183\/09031936.98.11030599","volume":"11","author":"R Marco de","year":"1998","unstructured":"de Marco R, Cerveri I, Bugiani M, Ferrari M, Verlato G. An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J. 1998;11(3):599\u2013605.","journal-title":"Eur Respir J"},{"issue":"9500","key":"201_CR67","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/S0140-6736(05)67632-5","volume":"366","author":"AMB Menezes","year":"2005","unstructured":"Menezes AMB, Perez-Padilla R, Jardim JRB, Mui\u00f1o A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875\u201381.","journal-title":"Lancet"},{"issue":"8","key":"201_CR68","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","volume":"70","author":"NA Hanania","year":"2015","unstructured":"Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015;70(8):748\u201356.","journal-title":"Thorax"},{"issue":"12","key":"201_CR69","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088\u201398.","journal-title":"N Engl J Med"},{"issue":"5","key":"201_CR70","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","volume":"184","author":"RA Dweik","year":"2011","unstructured":"Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL. Taylor DR; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"201_CR71","unstructured":"Global Strategy for Asthma Management and Prevention 2016. http:\/\/ginasthma.org\/2016-gina-report-global-strategy-for-asthma-management-and-prevention\/ . Accessed 12 May 2017."}],"container-title":["Clinical and Translational Allergy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13601-018-0201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13601-018-0201-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13601-018-0201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T06:07:52Z","timestamp":1693634872000},"score":1,"resource":{"primary":{"URL":"https:\/\/ctajournal.biomedcentral.com\/articles\/10.1186\/s13601-018-0201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1186\/s13601-018-0201-3","relation":{},"ISSN":["2045-7022"],"issn-type":[{"type":"electronic","value":"2045-7022"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"12 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}